The latest announcement is out from Health Catalyst ( (HCAT) ).
On February 20, 2025, Anita Pramoda resigned from the Health Catalyst Board, effective March 1, 2025, and the Board approved accelerating the vesting of her RSUs. Her resignation was not due to any conflict with the company. Health Catalyst reported strong financial results for 2024, with a total revenue of $307 million and an Adjusted EBITDA of $26 million, and anticipates further growth in 2025. The company also announced leadership changes, including the appointment of Dr. Jill Hoggard Green to the Board and promotions within the leadership team.
More about Health Catalyst
Health Catalyst, Inc. is a leading provider of data and analytics technology and services to healthcare organizations. The company focuses on delivering solutions that enhance healthcare outcomes through data-driven insights.
YTD Price Performance: -32.56%
Average Trading Volume: 696,249
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $301.2M
Learn more about HCAT stock on TipRanks’ Stock Analysis page.